Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 9:16:2829-2840.
doi: 10.2147/IDR.S408686. eCollection 2023.

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines

Waleed H Mahallawi  1 , Wael A Alharbi  1 , Sultan A Aloufi  1 , Nadir A Ibrahim  1 , Muntasir M Abdelrahman  2 , Bader A Alhomayeed  2 , Moutasem S Aboonq  3 , Saeed Awad M Alqahtani  3 , Emad S Rajih  4 , Abdulaziz M Bakhsh  4 , Ibrahim Sandokji  5
Affiliations

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines

Waleed H Mahallawi et al. Infect Drug Resist. .

Abstract

Background: Kidney transplant recipients (KTRs) commonly suffer from impaired immunity. KTRs' compromised immune response to COVID-19 vaccines indicates urgent revision of immunisation policies.

Methods: A cross-sectional study was conducted in Madinah, Saudi Arabia of 84 KTRs who had received at least one dose of a COVID-19 vaccine. ELISA was used to evaluate anti-spike SARS-CoV-2 IgG and IgM antibody levels in blood samples obtained one month and seven months after vaccination. Univariate and multivariate analyses were performed to identify associations between seropositive status and factors such as the number of vaccine doses, transplant age, and immunosuppressive therapies.

Results: The mean age of KTRs was 44.3 ± 14.7 years. The IgG antibody seropositivity rate (n=66, 78.5%) was significantly higher than the seronegativity rate (n=18, 21.4%) in the whole cohort (p<0.001). In KTRs seroconverting after one month (n=66), anti-SARS-CoV-2 IgG levels declined significantly between one month (median [IQR]:3 [3-3]) and seven months (2.4 [1.7-2.6]) after vaccination (p<0.01). In KTRs with hypertension, IgG levels significantly decreased between one and seven months after vaccination (p<0.01). IgG levels also decreased significantly in KTRs with a transplant of >10 years (p=0.02). Maintenance immunosuppressive regimens (triple immunosuppressive therapy and steroid-based and antimetabolite-based regimens) led to a significant decrease in IgG levels between the first and second sample (p<0.01). KTRs receiving three vaccine doses showed higher antibody levels than those receiving a single dose or two doses, but the levels decreased significantly between one (median [IQR]: 3 [3-3]) and seven months (2.4 [1.9-2.6]) after vaccination (p<0.01).

Conclusion: KTRs' humoral response after SARS-CoV-2 vaccination is dramatically inhibited and wanes. Antibody levels show a significant decline over time in KTRs with hypertension; receiving triple immunosuppressive therapy or steroid-based or antimetabolite-based regimens; receiving mixed mRNA and viral vector vaccines; and with a transplant of >10 years.

Keywords: COVID-19 vaccines; SARS-CoV-2; booster; humoral immune response; immunosuppression; kidney transplant recipients.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Correlation between IgG and IgM antibody levels at six months after vaccination.
Figure 2
Figure 2
Display of individual kidney transplant patients datapoints for IgG levels at 1- and 6-months post vaccination. Each line represents an individual patient.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924 - DOI - PMC - PubMed
    1. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020;26(6):729–734. doi:10.1016/j.cmi.2020.03.026 - DOI - PMC - PubMed
    1. Mahallawi WH. Humoral immune responses in hospitalized COVID-19 patients. Saudi J Biol Sci. 2021;28(7):4055–4061. doi:10.1016/j.sjbs.2021.04.032 - DOI - PMC - PubMed
    1. Zhang G, Nie S, Zhang Z, Zhang Z. Longitudinal change of severe acute respiratory syndrome coronavirus 2 antibodies in patients with coronavirus disease 2019. J Infect Dis. 2020;222(2):183–188. doi:10.1093/infdis/jiaa229 - DOI - PMC - PubMed
    1. Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020;71(15):778–785. doi:10.1093/cid/ciaa310 - DOI - PMC - PubMed